降脂药物和快速功能下降的风险:一个门德尔的随机化研究
Zhicheng Zhao1,2, Yu Wan1, Han Fu3
1Graduate school of Tianjin Medical University, Tianjin, 300070, China.
BMC medical genomics
|October 8, 2024
概括
这项研究调查了慢性病 (CKD) 中的脂质代谢,发现抑制HMGCR与较慢的功能下降有关. 在CKD患者中,PCSK9抑制与功能下降有负面关联.
科学领域:
- 遗传学和精准医学 遗传学和精准医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药物基因组学 药物基因组学
背景情况:
- 慢性病 (CKD) 存在重大风险,包括功能迅速下降,透析和死亡率.
- 脂质代谢越来越被认为是导致慢性病患者急性功能下降的潜在因素.
研究的目的:
- 调查药物向介导的脂质表型和慢性病患者的功能迅速下降之间的潜在因果关系.
- 利用门德尔随机化 (MR) 来探索与功能下降的遗传关联.
主要方法:
- 使用了基于数据的汇总的门德尔随机化 (SMR) 和反向方差加权的门德尔随机化 (IVW-MR).
- 用于药物向基因和编码低密度脂蛋白 (LDL) 胆固醇相关蛋白质的基因附近遗传变异的表达量特征位点 (eQTL).
- 分析了与快速功能下降进展的关联.
主要成果:
- SMR分析表明,高PCSK9表达与功能迅速下降 (OR=1.11,p=0.044) 之间存在潜在的关联.
- 通过IVW-MR分析发现,由HMGCR调解的LDL胆固醇与功能下降之间存在负相关性 (OR=0.74,p=0.003).
结论:
- 基因预测的HMGCR抑制与较慢的功能衰退有关.
- 基因预测PCSK9抑制表明与功能下降有负面关联.
- 建议进行临床试验,以验证PCSK9在预防功能下降方面的作用.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
579
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
579
01:11Renal Failure: Dose Adjustments
68
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
68
01:17Factors Affecting Renal Clearance: Renal Impairment
59
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
59
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
394
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
184
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
184
01:25Antihypertensive Drugs: Direct Renin Inhibitors
505
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
505